Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double Blind, Randomized, Controlled Clinical Investigation to Evaluate the Performance of Autocross-linked Hyaluronic Acid for the Treatment of Hypertrophic Scars

NCT04614415 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.

NCT NCT04614415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04614415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double Blind, Randomized, Controlled Clinical Investigation to Evaluate the Performance of Autocross-linked Hyaluronic Acid for the Treatment of Hypertrophic Scars
Lead sponsor
Fidia Farmaceutici s.p.a.
Phase
Not applicable
Overall status
Unknown status
Start date
January 14, 2020
Completion date
December 31, 2024
Enrollment
78 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic scar